日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Active Substances from the Micro-Immunotherapy Medicine 2LC1(®) Show In Vitro Anti-Cancer Properties in Colon, Prostate, and Breast Cancer Models and Immune-Enhancing Capabilities in Human Macrophages.

微免疫疗法药物 2LC1(®) 中的活性物质在结肠癌、前列腺癌和乳腺癌模型中显示出体外抗癌特性,并在人类巨噬细胞中显示出免疫增强能力

Jacques Camille, Marchesi Irene, Fiorentino Francesco Paolo, Marchand Flora, Chatelais Mathias, Floris Ilaria

MICA variant promotes allosensitization after kidney transplantation.

MICA 变异体促进肾移植后的同种异体致敏

Tonnerre Pierre, Gérard Nathalie, Chatelais Mathias, Poli Caroline, Allard Stéphanie, Cury Sylvie, Bressollette Céline, Cesbron-Gautier Anne, Charreau Béatrice